Comparative analysis of expression profiling of early-stage carcinogenesis using nodule-in-nodule-type hepatocellular carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 3, 2006, Pages 239-247

  Suk, Woo Nam ^a   Jong, Heun Lee ^a   Ji, Heon Noh ^a   Shi, Nae Lee ^b   Su, Young Kim ^a   Sug, Hyung Lee ^a   Cheol, Kyun Park ^c   Young, Min Ahn ^d   Won, Sang Park ^a   Nam, Jin Yoo ^a   Jung, Young Lee ^a,e  

^a The Catholic University of Korea   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Kyung Hee University   (South Korea)

^e The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Dysplatic nodule; Hepatocarcinogenesis; Hepatocellular carcinoma; Microarray; Nodule in nodule

Indexed keywords

OLIGONUCLEOTIDE;

ARTICLE; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE ASSOCIATION; DNA MICROARRAY; DOWN REGULATION; EXTRACTION; GENE CONTROL; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER NODULE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FOCAL NODULAR HYPERPLASIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS;

EID: 33644601320     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200603000-00003     Document Type: Article

References (27)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83:18-29.
2. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353:1253-1257.
3. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000; 24:245-250.
4. La CA, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998; 95:8847-8851.
5. Pang A, Ng IO, Fan ST, Kwong YL. Clinicopathologic significance of genetic alterations in hepatocellular carcinoma. Cancer Genet Cytogenet 2003; 146:8-15.
6. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991; 22:172-178.
7. Kojiro M. Pathology of early hepatocellular carcinoma: progression from early to advanced. Hepatogastroenterology 1998; 45 (Suppl 3):1203-1205.
8. Coleman WB. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003; 3:573-588.
9. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22:983-993.
10. Tornillo L, Carafa V, Sauter G, Moch H, Minola E, Gambacorta M, et al. Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma. Lab Invest 2002; 82:547-553.
11. Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M, Hirohashi S. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 2003; 37:198-207.
12. Hirohashi S. Pathology and molecular mechanisms of multistage human hepatocarcinogenesis. Princess Takamatsu Symp 1991; 22:87-93.
13. Eisen MB, Brown PO. DNA arrays for analysis of gene expression. Methods Enzymol 1999; 303:179-205.
14. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000; 405:827-836.
15. Stears RL, Martinsky T, Schena M. Trends in microarray analysis. Nat Med 2003; 9:140-145.
16. Park JY, Kim SY, Lee JH, Song J, Noh JH, Lee SH, et al. Application of amplified RNA and evaluation of cRNA targets for spotted-oligonucleotide microarray. Biochem Biophys Res Commun 2004; 325:1346-1352.
17. Saal LH, Troein C, VallonChristersson J, Gruvberger S, Borg A, Peterson C. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 2002; 3:SOFTWARE0003.
18. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30:e15 (1-10).
19. Liu ET. Classification of cancers by expression profiling. Curr Opin Genet Dev 2003; 13:97-103.
20. Schulze A, Downward J. Navigating gene expression using microarrays - a technology review. Nat Cell Biol 2001; 3:E190-E195.
21. Kaelin WG Jr. E2F1 as a target: promoter-driven suicide and small molecule modulators. Cancer Biol Ther 2003; 2:S48-S54.
22. Mundle SD, Saberwal G. Evolving intricacies and implications of E2F1 regulation. FASEB J 2003; 17:569-574.
23. Stanelle J, Stiewe T, Theseling CC, Peter M, Putzer BM. Gene expression changes in response to E2F1 activation. Nucleic Acids Res 2002; 30:1859-1867.
24. Cao Y, Dave KB, Doan TP, Prescott SM. Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. Cancer Res 2001; 61:8429-8434.
25. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68:729-777.
26. Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, Filmus J. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003; 125:89-97.
27. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001; 61:2129-2137.